AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018
May 10, 2018
30583_dirs_2018-05-09_edfe44b2-872a-4252-977f-b8767d5ee1ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-04-30
Reporting Person: Ajer Jeffrey Robert (EVP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-04-30 | Common Stock | A | 309 | $68.782 | Acquired | 53223 | Direct |
| 2018-05-07 | Common Stock | S | 309 | $85.960 | Disposed | 52914 | Direct |
Footnotes
F1: Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan.
F2: Trade made pursuant to a 10b5-1 plan executed on September 6, 2017.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19